Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2008
11/27/2008US20080293724 Methods Using Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide Mononitrate
11/27/2008US20080293722 Ion Channel Modulators
11/27/2008US20080293703 Topical Preparation and Method for Transdermal Delivery and Localization of Therapeutic Agents
11/27/2008US20080293702 Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use
11/27/2008US20080293701 1-Acylamino-2-Hydroxy-3-Amino- -Arylalkanes as Renin Inhibitors
11/27/2008US20080293697 Pyrazolo[4,3-D]Pyrimidines
11/27/2008US20080293691 Treatment Method
11/27/2008US20080293690 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293650 Fused Heterocyclic Compounds and Use Thereof
11/27/2008US20080293644 Guava extract
11/27/2008US20080293642 C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same
11/27/2008US20080293640 Polypeptide inhibitors of HSP27 kinase and uses therefor
11/27/2008US20080293635 Angiogenic composition
11/27/2008US20080293623 Enriched haptoglobin polymers for the treatment of disease
11/27/2008US20080293034 Organ arrest, protection, preservation and recovery
11/27/2008US20080292733 Antioxidant and Fe2+ Chelating Properties of Herbal Extracts
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292695 Carvedilol forms, compositions, and methods of preparation thereof
11/27/2008US20080292685 Transdermal Patch Containing Isosorbide Dinitrate and Bisoprolol
11/27/2008US20080292681 Use of Dha, Epa or Dha-Derived Epa for Treating a Pathology Associated with Cellular Oxidative Damage
11/27/2008US20080292678 Medical articles having enzymatic surfaces for localized therapy
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292608 Compounds and Compositions as Ppar Modulators
11/27/2008US20080292596 Edible mushroom-producing fungi; for producing reduced, methylated, biologically active forms of folate such as 5-methyltetrahydrofolate (5-MTHF) in a form that is easily ingested and absorbed in the intestines of a human
11/27/2008US20080292582 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE102007024470A1 New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis
11/27/2008CA2688057A1 Novel case of renin inhibitors
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/26/2008EP1995321A2 Gene disruptions, compositions and methods relating thereto
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1995240A1 Quinolone derivative or pharmaceutically acceptable salt thereof
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
11/26/2008EP1994029A2 Potassium channel inhibitors
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008EP1993672A2 Na/k-atpase ligand
11/26/2008EP1993580A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction
11/26/2008EP1993551A2 Potassium channel inhibitors
11/26/2008EP1993541A2 Antihypertensive therapy
11/26/2008EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression
11/26/2008EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/26/2008EP1588173B1 Affinity fishing for ligands and proteins receptors
11/26/2008EP1546373B1 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
11/26/2008EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/26/2008EP1480642B1 Peroxisome proliferator activated receptor modulators
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1419173B1 Peptides that bind to atherosclerotic lesions
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008EP1328267B1 Method of treating cancer using dithiocarbamate derivatives
11/26/2008EP1155015B1 Process for the production of tert-butyl (e)-(6-¬2-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl vinyl (4r,6s)-2,2-dimethyl¬1,3 dioxan-4-yl)acetate
11/26/2008CN101312987A Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia
11/26/2008CN101312973A Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
11/26/2008CN101312966A Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands
11/26/2008CN101312661A Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
11/26/2008CN101311273A Biosynthesis gamma-aminobutyric acid preparation and method for preparing same
11/26/2008CN101311181A Aminomethyl-substituted thiazolobenzimidazole derivative
11/26/2008CN101310779A Device and medicinal preparation containing neuroregulation protein
11/26/2008CN101310766A New use of neuroregulation protein
11/26/2008CN101310765A Safe dose of neuroregulation protein applied to human
11/26/2008CN101310760A Traditional Chinese medicine for preventing and treating metabolism syndrome
11/26/2008CN101310751A Traditional Chinese medicine composition for replenishing qi and blood, preparation method and quality control method thereof
11/26/2008CN101310747A Novel traditional Chinese drug composition for treating apoplectic hemiplegia and removing phlegm
11/26/2008CN101310737A Medicine for treating ischemic stroke and its preparation method
11/26/2008CN101310736A External medicine for treating coronary heart disease and preparation method thereof
11/26/2008CN101310733A Medicine composition for treating the cerebrovascular disease and preparation method thereof
11/26/2008CN101310728A Free protein blood of pig injection and use thereof
11/26/2008CN101310721A Use of a magnesium isotope for treating hypoxia and a medicament comprising the same
11/26/2008CN101310712A Nifedipine controlled release preparation and preparation method thereof
11/26/2008CN101310622A Method for preparing microbial fat with low-content non saponifying objects and the fat
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436468C A kind of compound, its pharmaceutical composition and its medicinal and health uses
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436415C Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
11/26/2008CN100435882C System and method for treating cardiac arrhythmias with fibroblast cells
11/26/2008CN100435842C Chinese-medicinal preparation for treating hypertension and its making method
11/26/2008CN100435841C Medicament for treating phlebitis of mammary gland
11/26/2008CN100435825C Application of anemarrhena extract in preparing mediciation for preventing and curing abnormal rapidity heart rate and essential hyperension
11/26/2008CN100435811C Apoplexy treating medicine composition
11/26/2008CN100435807C Pharmaceutical gel composition
11/26/2008CN100435803C Use of taurine in preparation of injection containing puerarin
11/26/2008CN100435798C Preparation of ligustrazine and ligustrazine salt drop pills utilizing nano technology
11/26/2008CN100435796C Cardioprotective delta opioid receptor agonists and methods of using same
11/26/2008CN100435794C Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/26/2008CN100435792C Application of butylbenzene phthalein homolog in preparation of medicine for treating cerebral ischemia disease
11/26/2008CN100435790C EGCG-zinc complex solid dispersion, its preparation method and application
11/26/2008CN100435783C Orally administered composition containing fat soluble ingredient of red sage root
11/25/2008US7456297 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456195 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
11/25/2008US7456190 autoimmune disease; antiinflammatory agents; bone disorders; central nervous system disorders; cardiovascular disorders; Alzheimer's disease; antihistamines; antiallergens
11/25/2008US7456187 Cardiac arrythmias; 5-Phenyl-N-(pyridin-2-ylmethyl)furo[2,3-d]pyrimidin-4-amine
1 ... 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 ... 1595